Clinical Trial Update: GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults [Phase 1]

View source ↗

Summary

Stanford is conducting a Phase 1 study of GPC2-CAR T cell therapy for relapsed or refractory medulloblastoma and related CNS embryonal tumors. The trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor of the Cns
• Central Nervous System Embryonal Tumor
• Cns Neuroblastoma
• Embryonal Tumor with Multilayered Rosettes
• Medulloblastoma
• Pineoblastoma

Drugs mentioned

• GPC2-CAR T cell therapy

Snippet

Sponsor: Stanford University | Conditions: Medulloblastoma, Central Nervous System Embryonal Tumor | Phase 1 | Status: RECRUITING